Vital Pulp Therapy Protocol for Symptomatic Pulpal Pain

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current clinical methods fail to effectively manage symptomatic pulpal pain in vital teeth, often leading to unnecessary endodontic procedures and compromising pulp vitality.

Innovation Solution

A structured, biologically respectful clinical protocol integrating pulp vitality testing, selective caries excavation, antimicrobial disinfection, biocompatible pulp-capping agents, and strategic follow-up to preserve dental organ integrity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If root canal therapy is performed to relieve pulpal pain, then pain relief is achieved, but pulp vitality is lost

Engineering Contradiction:
Improvepulpal painVSAvoidpulp vitality
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent introduces an intermediary substance (biocompatible pulp-capping agent) that mediates between the irritated pulp tissue and the external environment. This agent acts as a protective barrier that allows pain relief without requiring complete pulp removal, thus preserving vitality while managing symptoms.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent extracts only the necessary carious tissue and irritants from the tooth structure, rather than removing the entire pulp. This selective extraction approach relieves pain by removing the source of irritation while leaving the vital pulp tissue intact for preservation.

Inventive Principle:
Principle #2Taking out (Extraction)

2Object-affected harmful factors

If emergency pulpal access is performed to alleviate intrapulpal pressure, then immediate symptom relief is achieved, but risk of microbial invasion increases

Engineering Contradiction:
Improveintrapulpal pressureVSAvoidmicrobial contamination
Core Design Contradiction:
Object-affected harmful factorsVSObject-generated harmful factors

Solution Approach 1:

The patent uses an intermediary pulp-capping agent that seals the pulpal access site. This agent serves as a barrier that prevents microbial contamination while allowing the pressure relief achieved through access to be maintained, thus resolving the contradiction between symptom relief and infection prevention.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent applies preliminary disinfection and sealing measures immediately after pulpal access is created. By performing these protective actions before microbial contamination can occur, the method prevents infection while maintaining the benefits of pressure relief.

Inventive Principle:
Principle #10Preliminary action

3Object-affected harmful factors

If invasive endodontic procedures are performed to treat symptomatic pulpitis, then pain management is improved, but structural and biological integrity is compromised

Engineering Contradiction:
Improvepulpal inflammationVSAvoiddental organ integrity
Core Design Contradiction:
Object-affected harmful factorsVSStrength

Solution Approach 1:

The patent extracts only the diseased or irritated portions of the pulp tissue and carious dentin, rather than removing the entire pulp. This conservative extraction approach manages inflammation while preserving the structural framework and biological integrity of the dental organ.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent applies treatment locally to the specific area of pulpal irritation rather than undertaking comprehensive endodontic intervention. The pulp-capping agent is applied locally at the site of irritation, providing targeted therapy that manages inflammation without compromising overall dental organ integrity.

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS12496176B1Method for mitigating pulpal pain in symptomatic patients and preventing unnecessary endodontic treatment
Publication Date: 2025.12.16 ROMERO VASQUEZ MARIA I
  • US12496176B1 patent drawing

AI summary

The present invention provides a structured, biologically based clinical method for mitigating symptomatic pulpal conditions and preventing unnecessary endodontic treatment. Targeted at teeth with vital pulps and reversible inflammation, the protocol combines selective caries removal, pulp protection using calcium hydroxide or MTA, a sedative zinc oxide-eugenol base, and provisional sealing with moisture-setting cement. The method includes diagnostic, therapeutic, and follow-up steps, with one-week, one-month, and three-month evaluations to assess healing. If symptoms persist, root canal therapy is initiated; if asymptomatic, definitive restoration is performed. Annual monitoring ensures long-term pulpal stability. This reproducible approach prioritizes pain control, infection management, pulp preservation, and tooth longevity. It provides an evidence-based alternative to conventional endodontics, reducing overtreatment while supporting functional and biological integrity of the dental organ.